Antitumour activity of Helix hemocyanin against bladder carcinoma permanent cell lines

References

• Decker H, Hellmann N, Jaenicke E, et al. Minireview: recent progress in hemocyanin research. Integr Comp Biol. 2007;47(4):631–644.
   PubMed Web of Science ®Google Scholar
• Markl J. Evolution of molluscan hemocyanin structures. Biochim Biophys Acta. 2013;1834(9):1840–1852.
   PubMed Web of Science ®Google Scholar
• Gatsogiannis C, Hofnagel O, Markl J, et al. Structure of mega-hemocyanin reveals protein origami in snails. Structure. 2015;23(1): 93–103.
   Google Scholar
• Dolashka P, Zal F, Dolashki A, et al. ESI-MS and MALLS analysis of quaternary structure of molluscan hemocyanins. J Mass Spectrom. 2012;47(7):940–947.
   PubMed Web of Science ®Google Scholar
• Wu J, Cunningham AL, Dehghani F, et al. Comparison of Haliotis rubra hemocyanin isoforms 1 and 2. Gene Reports. 2016;4:123–130.
   Web of Science ®Google Scholar
• Sandra K, Dolashka-Angelova P, Devreese B, et al. New insights in Rapana venosa hemocyanin N-glycosylation resulting from on-line mass spectrometric analyses. Glycobiology. 2006;17(2):141–156.
   PubMed Web of Science ®Google Scholar
• Dolashka P, Velkova L, Shishkov S, et al. Glycan structures and antiviral effect of the structural subunit RvH2 of Rapana hemocyanin. Carbohydr Res. 2010;345(16):2361–2367.
   PubMed Web of Science ®Google Scholar
• Wuhrer M, Robijn ML, Koeleman CA, et al. A novel Gal(beta1-4)Gal(beta1-4)Fuc(alpha1-6)-core modification attached to the proximal N-acetylglucosamine of keyhole limpet haemocyanin (KLH) N-glycans. Biochem J. 2004;378(Pt 2):625–632.
   PubMedGoogle Scholar
• Becker MI, Arancibia S, Salazar F, et al. Mollusk hemocyanins as natural immunostimulants in biomedical applications. In: Huynh G, Duc T, editors. Immune response activation. Rijeka (Croatia): InTech; 2014. DOI: 10.5772/57552
   Google Scholar
• Del Campo M, Arancibia S, Nova E, et al. Hemocyanins as immunostimulants. Rev Med Chil. 2011;139(2):236–246.
   PubMed Web of Science ®Google Scholar
• Arancibia S, Salazar F, Becker MI. Hemocyanins in the immunotherapy of superficial bladder cancer. In: Canda A, editor. Bladder cancer-from basic science to robotic surgery. Rijeka (Croatia): InTech; 2012. DOI: 10.5772/10
   Google Scholar
• Coates CJ, Decker H. Immunological properties of oxygen-transport proteins: hemoglobin, hemocyanin and hemerythrin. Cell Mol Life Sci. 2017;74(2):293–317.
   PubMed Web of Science ®Google Scholar
• Lammers RJ, Witjes WP, Janzing-Pastors MH, et al. Intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin compared with intravesical mitomycin in patients with non–muscle-invasive bladder cancer: results from a prospective randomized phase III trial. J Clin Oncol. 2012;30(18):2273–2279.
   PubMed Web of Science ®Google Scholar
• Krug LM, Ragupathi G, Hood C, et al. Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin. Clin Cancer Res. 2004;10(18 Pt 1):6094–6100.
   PubMed Web of Science ®Google Scholar
• Lamm DL, Dehaven JI, Riggs DR. Keyhole limpet hemocyanin immunotherapy of bladder cancer: laboratory and clinical studies. European urology. 2000;37(Suppl.3):41–44.
   PubMedGoogle Scholar
• Markl J, Lieb B, Gebauer W, et al. Marine tumor vaccine carriers: structure of the molluscan hemocyanins KLH and HtH. J Cancer Res Clin Oncol. 2001;127(Suppl.2):R3–9.
   PubMedGoogle Scholar
• Kurokawa T, Wuhrer M, Lochnit G, et al. Hemocyanin from the keyhole limpet Megathura crenulata (KLH) carries a novel type of N-glycans with Gal(beta1-6)Man-motifs. Eur J Biochem. 2002;269(22):5459–5473.
   PubMedGoogle Scholar
• Coates CJ, Nairn J. Diverse immune functions of hemocyanins. Dev Comp Immunol. 2014;45(1):43–55.
   PubMed Web of Science ®Google Scholar
• Dolashka-Angelova P, Lieb B, Velkova L, et al. Identification of glycosylated sites in Rapana hemocyanin by mass spectrometry and gene sequence, and their antiviral effect. Bioconjugate chemistry. 2009;20(7):1315–1322.
   PubMed Web of Science ®Google Scholar
• Dolashka P, Voelter W. Antiviral activity of hemocyanins. Invertebr Surviv J. 2013;10:120–127.
   Web of Science ®Google Scholar
• Dolashka P, Dolashki A, Beeumen JV, et al. Antimicrobial activity of molluscan hemocyanins from Helix and Rapana snails. Curr Pharm Biotechnol. 2016;17(3):263–270.
   PubMed Web of Science ®Google Scholar
• Moltedo B, Faunes F, Haussmann D, et al. Immunotherapeutic effect of Concholepas hemocyanin in the murine bladder cancer model: evidence for conserved antitumor properties among hemocyanins. J Urol. 2006;176(6):2690–2695.
   PubMed Web of Science ®Google Scholar
• Arancibia S, Espinoza C, Salazar F, et al. A novel immunomodulatory hemocyanin from the limpet Fissurella latimarginata promotes potent anti-tumor activity in melanoma. PloS one. 2014;9(1):e87240. DOI: 10.1371/journal.pone.0087240
   PubMed Web of Science ®Google Scholar
• Zhong T-Y, Arancibia S, Born R, et al. Hemocyanins stimulate innate immunity by inducing different temporal patterns of proinflammatory cytokine expression in macrophages. J Immunol. 2016;196(11):4650–4662.
   PubMed Web of Science ®Google Scholar
• Zheng L, Zhao X, Zhang P, et al. Hemocyanin from shrimp Litopenaeus vannamei has antiproliferative effect against HeLa cell in vitro. PloS One. 2016;11(3):e0151801. DOI: 10.1371/journal.pone.0151801
   PubMed Web of Science ®Google Scholar
• Dolashka P, Velkova L, Iliev I, et al. Antitumor activity of glycosylated molluscan hemocyanins via Guerin ascites tumor. Immunol Invest. 2011;40(2):130–149.
   PubMed Web of Science ®Google Scholar
• Dolashka-Angelova P, Stefanova T, Livaniou E, et al. Immunological potential of Helix vulgaris and Rapana venosa hemocyanins. Immunol Invest. 2008;37(8):822–840.
   Google Scholar
• Antonova O, Yossifova L, Staneva R, et al. Changes in the gene expression profile of the bladder cancer cell lines after treatment with Helix lucorum and Rapana venosa hemocyanin. J BUON. 2015;20(1):180–187.
   PubMed Web of Science ®Google Scholar
• Jacobs BL, Lee CT, Montie JE. Bladder cancer in 2010: how far have we come? CA Cancer J Clin. 2010;60(4):244–272.
   PubMed Web of Science ®Google Scholar
• Li C, Li H, Zhang T, et al. Discovery of Apo-A1 as a potential bladder cancer biomarker by urine proteomics and analysis. Biochem Biophys Res Commun. 2014;446(4):1047–1052.
   PubMed Web of Science ®Google Scholar
• Chen Y-T, Chen C-L, Chen H-W, et al. Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology. J Proteome Res. 2010;9(11):5803–5815.
   PubMed Web of Science ®Google Scholar
• Antonova O, Toncheva D, Rammensee H-G, et al. In vitro antiproliferative effect of Helix aspersa hemocyanin on multiple malignant cell lines. Zeitschrift für Naturforschung C. 2014;69(7-8):325–334.
   PubMed Web of Science ®Google Scholar
• Boyanova O, Dolashka P, Toncheva D, et al. In vitro effect of molluscan hemocyanins on CAL-29 and T-24 bladder cancer cell lines. Biomed Rep. 2013;1(2):235–238.
   PubMedGoogle Scholar
• Stenzl A, Dolashki A, Stevanovic S, et al. Cytotoxic effects of Rapana venosa hemocyanin on bladder cancer permanent cell lines. J US-China Med Sci. 2016;13:179–188.
   Google Scholar
• De Smet L, Dimitrov I, Debyser G, et al. The cDNA sequence of three hemocyanin subunits from the garden snail Helix lucorum. Gene. 2011;487(2):118–128.
   PubMed Web of Science ®Google Scholar
• Velkova L, Dimitrov I, Schwarz H, et al. Structure of hemocyanin from garden snail Helix lucorum. Comp Biochem Physiol B Biochem Mol Biol. 2010;157(1):16–25.
   PubMed Web of Science ®Google Scholar
• Dolashka-Angelova P, Schwarz H, Dolashki A, et al. Oligomeric stability of Rapana venosa hemocyanin (RvH) and its structural subunits. Biochim Biophys Acta. 2003;1646(1):77–85.
   PubMed Web of Science ®Google Scholar
• Velkova L, Dolashki A, Dolashka P. Carbohydrate structure of molluscan hemocyanins from snails Helix lucorum and Rapana venosa, determined by mass spectrometry. J. BioSci. Biotechnol. 2015, SE/ONLINE:75–85.
   Google Scholar
• Stepan A, Ciuca M, Simionescu C, et al. Immunoexpression of N-cadherin, twist and vimentin in bladder urothelial carcinomas. Curr Health Sci J. 2015; 41(3):219–226.
   PubMedGoogle Scholar
• Tyan YC, Yang MH, Chen SCJ, et al. Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma. RCM 2011;25(19):2851–2862.
   Google Scholar
• Zhao J, Dong D, Sun L, et al. Prognostic significance of the epithelial-to-mesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer. Int Braz J Urol. 2014;40(2):179–189.
   PubMed Web of Science ®Google Scholar
• Horvatovich P, Bischoff R, editors. Comprehensive biomarker discovery and validation for clinical application. London (UK): Royal Society of Chemistry; 2013. DOI: 10.1039/9781849734363
   Google Scholar
• Song Y, Luo Q, Long H, et al. Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma. Mol Cancer. 2014;13:65. DOI: 10.1186/1476-4598-13-65
   PubMed Web of Science ®Google Scholar
• Liu K, Tang Z, Huang A, et al. Glyceraldehyde-3-phosphate dehydrogenase promotes cancer growth and metastasis through upregulation of SNAIL expression. Int J Oncol. 2017;50(1):252–262.
   PubMed Web of Science ®Google Scholar
• Yang N, Feng S, Shedden K, et al. Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification. Clin Cancer Res. 2011;17(10):3349–3359.
   PubMed Web of Science ®Google Scholar
• Nicolas E, Parisot P, Pinto-Monteiro C, et al. Involvement of human ribosomal proteins in nucleolar structure and p53-dependent nucleolar stress. Nat Commun. 2016;7:11390. DOI: 10.1038/ncomms11390
   PubMed Web of Science ®Google Scholar
• Fan N-J, Kang R, Ge X-Y, et al. Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer. Diagn Pathol. 2014;9:53. DOI: 10.1186/1746-1596-9-53
   PubMed Web of Science ®Google Scholar
• Dieplinger H, Ankerst DP, Burges A, et al. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1127–1133.
   PubMed Web of Science ®Google Scholar
• Zamanian-Daryoush M, DiDonato JA. Apolipoprotein AI and cancer. Front Pharmacol. 2015;6:265. DOI: 10.3389/fphar.2015.00265
   PubMed Web of Science ®Google Scholar